1. Home
  2. SCPH vs EVG Comparison

SCPH vs EVG Comparison

Compare SCPH & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • EVG
  • Stock Information
  • Founded
  • SCPH 2013
  • EVG 2005
  • Country
  • SCPH United States
  • EVG United States
  • Employees
  • SCPH N/A
  • EVG N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • EVG Investment Managers
  • Sector
  • SCPH Health Care
  • EVG Finance
  • Exchange
  • SCPH Nasdaq
  • EVG Nasdaq
  • Market Cap
  • SCPH 173.6M
  • EVG 149.9M
  • IPO Year
  • SCPH 2017
  • EVG N/A
  • Fundamental
  • Price
  • SCPH $3.25
  • EVG $11.19
  • Analyst Decision
  • SCPH Strong Buy
  • EVG
  • Analyst Count
  • SCPH 2
  • EVG 0
  • Target Price
  • SCPH $15.00
  • EVG N/A
  • AVG Volume (30 Days)
  • SCPH 267.8K
  • EVG 49.4K
  • Earning Date
  • SCPH 03-12-2025
  • EVG 01-01-0001
  • Dividend Yield
  • SCPH N/A
  • EVG 8.68%
  • EPS Growth
  • SCPH N/A
  • EVG N/A
  • EPS
  • SCPH N/A
  • EVG N/A
  • Revenue
  • SCPH $30,278,000.00
  • EVG N/A
  • Revenue This Year
  • SCPH $172.27
  • EVG N/A
  • Revenue Next Year
  • SCPH $131.75
  • EVG N/A
  • P/E Ratio
  • SCPH N/A
  • EVG N/A
  • Revenue Growth
  • SCPH 303.87
  • EVG N/A
  • 52 Week Low
  • SCPH $3.08
  • EVG $9.13
  • 52 Week High
  • SCPH $6.54
  • EVG $10.86
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 43.27
  • EVG 54.97
  • Support Level
  • SCPH $3.09
  • EVG $11.14
  • Resistance Level
  • SCPH $3.87
  • EVG $11.27
  • Average True Range (ATR)
  • SCPH 0.20
  • EVG 0.10
  • MACD
  • SCPH 0.00
  • EVG -0.01
  • Stochastic Oscillator
  • SCPH 20.65
  • EVG 55.56

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

Share on Social Networks: